Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruption
R Gröning, A Dernstedt, C Ahlm, J Normark… - Frontiers in …, 2023 - frontiersin.org
Peripheral B cell depletion via anti-CD20 treatment is a highly effective disease-modifying
treatment for reducing new relapses in multiple sclerosis (MS) patients. A drawback of …
treatment for reducing new relapses in multiple sclerosis (MS) patients. A drawback of …
Vaccine-induced correlate of protection against fatal COVID-19 in the old and frail during waves of neutralization resistant variants of concern
L Vikström, P Fjällström, YD Gwon, DJ Sheward… - medRxiv, 2023 - medrxiv.org
Background To inform future preventive measures including repeated vaccinations, we have
searched for a clinically useful immune correlate of protection against fatal Covid-19 among …
searched for a clinically useful immune correlate of protection against fatal Covid-19 among …